País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
ENROFLOXACIN
Virbac S.A.
QJ01MA90
100 Mg/Ml
Solution for Injection
Antibacterial
Bovine
2009-07-10
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Powerflox 100 mg/ml solution for injection for cattle and pigs Enrofloxacin 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection Clear yellow solution practically free from particles 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle: Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis and coli-septicaemia) and secondary bacterial infections subsequent to viral infections (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. Treatment of local signs (inflammation, milk quality and yield) associated with peracute/acute mastitis in lactating dairy cattle caused by _E. coli, _where herd history and previous sensitivity testing indicate enrofloxacin as the drug of choice. Pigs: Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (pasteurellosis, mycoplasmosis, coli- bacillosis and coli-septicaemia) and multifactorial diseases such as enzootic pneumonia where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. 4.3 CONTRAINDICATIONS Do not use for prophylaxis. Do not use in case of resistance against quinolones. Do not use in case of disturbances in growth of cartilages and/or during injury of locomotory system particularly on functionally loaded joints or due to body weight loaded joints. Do not use in case of hypersensitivity to the active substance, or to any of the excipients. ACTIVE SUBSTANCE: 1 ml of Leer el documento completo